Pieter Rottiers

Amministratore Delegato presso Intrexon ActoBiotics NV

Consumer Services

Health Technology

Posizioni attive di Pieter Rottiers

Società	Posizione	Inizio	Fine
Intrexon ActoBiotics NV Intrexon ActoBiotics NV BiotechnologyHealth Technology Intrexon ActoBiotics NV manufactures biopharmaceutical products. It focuses on the development and commercialization of a new generation of biological drugs. The company represents a novel concept for oral administration of therapeutic proteins, and is designed to be safer and more effective than injectable biopharmaceuticals. Intrexon Actobioticswas founded by Mark Vaeck, Emil Pot and Bernard Coulie in June 2006 and is headquartered in Zwijnaarde, Belgium.	Direttore/Membro del Consiglio	-	-
	Amministratore Delegato	-	-
	Direttore Tecnico/Scientifico/R&S	09/10/2013	-
	Corporate Officer/Principal	21/08/2009	09/10/2013

Società	Posizione	Inizio	Fine
Vlaams Instituut voor Biotechnologie - Flanders Institute Vlaams Instituut voor Biotechnologie - Flanders Institute Other Consumer ServicesConsumer Services Vlaams Instituut voor Biotechnologie - Flanders Institute operates as a non-profit organization, provides research and development services. It specializes in translating basic scientific results into pharmaceutical, agricultural and industrial applications. The company was founded on January 1, 1996 and is headquartered in Ghent, Belgium.	Corporate Officer/Principal	01/01/2006	01/01/2006

Ghent University

Doctorate Degree

Distribuzione geografica

Belgio

Posizioni

Corporate Officer/Principal	2
Director/Board Member	1
Chief Executive Officer	1

Settori

Consumer Services	3
Health Technology	2

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Aziende private	1
Intrexon ActoBiotics NV Intrexon ActoBiotics NV BiotechnologyHealth Technology Intrexon ActoBiotics NV manufactures biopharmaceutical products. It focuses on the development and commercialization of a new generation of biological drugs. The company represents a novel concept for oral administration of therapeutic proteins, and is designed to be safer and more effective than injectable biopharmaceuticals. Intrexon Actobioticswas founded by Mark Vaeck, Emil Pot and Bernard Coulie in June 2006 and is headquartered in Zwijnaarde, Belgium.	Health Technology

Aziende private

Health Technology